Summary
To determine the impact of both short- and longterm “near-normoglycaemia” on insulin resistance in Type 1 (insulin-dependent) diabetes hepatic glucose production (mg · kg−1 · min−1) and peripheral glucose utilisation (“M-value”, mg · kg−1 · min−1) were estimated during an euglycaemic hyperinsulinaemic clamp (10 mU · kg · min) in patients with either good (HbA1c<5.8%, groups A and B) or poor (HbA1c>7.5%, groups C and D) long-term metabolic control (time > 12 months) and in healthy subjects (HbA1c: 5.08±0.20%; n=8). To this end blood glucose was stabilized at 6.7 mmol/l by overnight (t=12 h) i.v. regular insulin in groups (n=8 each) A (HbA1c: 5.49±0.46%) and C (HbA1c: 8.83±1.20%),while groups B (HbA1c:5.55±0.19%) andD (HbA1c: 8.51±1.09%) were kept overnight on long-acting insulin without feed-back control of blood glucose before euglycaemic clamping. Thereby, pre-equilibration of blood glucose at 6.7 mmol/l was shown to normalize basal hepatic glucose production (A: 2.27±0.48; C 2.50±0.57 mg · kg−1 · min−1) despite different HbA1c values, whereas basal hepatic glucose production stayed elevated in groups B (3.09±0.38 mg · kg−1 · min−1) and D (3.21±0.58 mg · kg−1 · min−1) with poor actual glycaemia (B: 10.9±4.6; D: 12.1±4.6 mmol/l). To restitute peripheral glucose utilisation close to normal (healthy subjects: 13.99±2.13; A: 12.12±2.67; B: 8.72±3.0; C: 10.27±1.69; D: 7.10±2.31 mg · kg−1 · min−1; healthy subjects vs A: NS; healthy subjects vs B, C, D: p<0.05) both long-term (HbA1c<5.8%) and acute nearnormoglycaemia by 12-h i. v. insulin pre-treatment were required (group A). We conclude that good long-term glucose control per se is unable to normalize hepatic and peripheral glucose metabolism in Type 1 diabetic patients unless actual near-normoglycaemia is provided consistently, e.g. by i.v. overnight infusion of regular insulin.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
DeFronzo RA, Hendler R, Simonson D (1982) Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31: 795–801
DeFronzo RA, Simonson D, Ferrannini E (1982) Hepatic and peripheral insulin resistance: a common feature of type 2 (noninsulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23: 313–319
Pedersen O, Beck-Nielsen H (1987) Insulin resistance and insulin-dependent diabetes mellitus. Diabetes Care 10: 516–523
Yki-Järvinen H, Koivisto VA (1986) Natural course of insulin resistance in type 1 diabetes. N Engl J Med 315: 224–230
Singh BM, Palma MA, Nattrass M (1987) Multiple aspects of insulin resistance. Comparison of glucose and intermediary metabolite response to incremental insulin infusion in IDDM subjects of short and long duration. Diabetes 36: 740–748
Nijs HGT, Radder JK, Fröhlich M, Krans HMJ (1988) Insulin action is normalized in newly diagnosed type 1 diabetic patients after three months of insulin treatment. Metabolism 37: 473–478
Nijs HGT, Radder JK, Fröhlich M, Krans HMJ (1989) The course and determinants of insulin action in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 20–27
Yki-Järvinen H, Koivisto VA (1984) Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab 58: 659–666
Lager I, Lönnroth R, Schenck H, Smith U (1983) Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. Br Med J 287: 1661–1664
Beck-Nielsen H, Richelsen B, Hasling C, Hother-Nielsen O, Heding L, Sorensen NS (1984) Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes 33: 832–837
Arslanian S, Nixon PA, Becker D, Drash AL (1990) Impact of physical fitness and glycaemic control on in vivo insulin action in adolescents with IDDM. Diabetes Care 13: 9–15
Waldhäusl W (1986) The physiological basis of insulin treatment — clinical aspects. Diabetologia 29: 837–849
Perriello G, DeFeo P, Torlone E et al. (1991) The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability and dependency on glucose counterregulation and insulin sensitivity. Diabetologia 34: 21–28
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
Bratusch-Marrain PR, Vierhapper H, Komjati M, Waldhäusl W (1985) Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man. Diabetologia 28: 671–676
Bratusch-Marrain PR, Smith D, DeFronzo RA (1982) The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55: 973–982
Hother-Nielsen O, Schmitz O, Bak J, Beck-Nielsen H (1987) Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. Diabetologia 30: 834–840
Waldhäusl WK, Bratusch-Marrain PR, Gasic S, Korn A, Nowotny P (1979) Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17: 221–227
Waldhäusl W, Bratusch-Marrain PR, Kruse V, Jensen I, Nowotny P, Vierhapper H (1985) Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin dependent diabetic patients. Diabetes 34: 166–173
Somogyi M (1930) A method for the precipitation of blood filtrates for the determination of sugar. J Biol Chem 86: 655–663
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82: 420–430
Waldhäusl WK, Gasic S, Bratusch-Marrain PR, Korn A, Nowotny P (1982) Feedback inhibition by biosynthetic human insulin release in healthy human subjects. Am J Physiol 243: E476-E482
Sacca L, Hendler R, Sherwin R (1978) Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endocrinol Metab 47: 1160–1163
Blackard WG, Nelson NC (1970) Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes 19: 302–306
Wilczek H, Gunnarsson R, Felig P, Östman J, Groth CG, Wahren J (1991) Normalization of hepatic glucose regulation despite systemic insulin delivery. Studies in patients with pancreatic transplantation for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 345–349
Yki-Järvinen H, Helve E, Koivisto VA (1987) Hyperglycaemia decreases glucose uptake in type 1 diabetes. Diabetes 36: 892–896
Waldhäusl W, Bratusch-Marrain P, Komjati M, Breitenecker F, Troch I (1992) Blood glucose response to stress hormone exposure in healthy man and insulin dependent diabetic patients: prediction by computer modeling. IEEE Transactions on Biomedical Engineering 39: 779–790
Lisato G, Cusin I, Tiengo A, Del Prato S, Jeanrenaud B (1992) The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats. Diabetologia 35: 310–315
Unger RH, Grundy S (1985) Hyperglycemia as inducer as well as consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28: 119–121
Yki-Järvinen H (1990) Acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia 33: 579–585
Vuorinen-Markkola H, Koivisto VA, Yki-Järvinen H (1992) Mechanisms of hyperglycaemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes 41: 571–580
Hansen IL, Cryer PE, Rizza A (1985) Comparison of insulinmediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects. Diabetes 34: 751–766
Kahn BB, Flier JS (1990) Regulation of glucose-transporter gene expression in vitro and in vivo. Diabetes Care 13: 548–564
Baly DL, Horuk R (1987) Dissociation of insulin-stimulated glucose transport from the translocation of glucose carriers in rat adipose cells. J Biol Chem 262: 21–24
Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA (1990) Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients. Diabetes 39: 157–167
Derfler K, Waldhäusl W, Zyman HJ, Howorka K, Holler C, Freyler H (1986) Diabetes care in a rural area: clinical and metabolic evaluation. Diabetes Care 9: 509–517
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fasching, P., Ratheiser, K., Damjancic, P. et al. Both acute and chronic near-normoglycaemia are required to improve insulin resistance in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36, 346–351 (1993). https://doi.org/10.1007/BF00400239
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400239